Reuters logo
BRIEF-NewLink Genetics announces clinical collaboration with AstraZeneca​
September 25, 2017 / 10:20 AM / in 22 days

BRIEF-NewLink Genetics announces clinical collaboration with AstraZeneca​

Sept 25 (Reuters) - NewLink Genetics Corp

* Newlink Genetics announces clinical collaboration to evaluate IO-based combination therapies in pancreatic cancer

* NewLink Genetics Corp - ‍Phase 2 trial will be funded equally by both companies, with NewLink Genetics serving as study sponsor​

* NewLink Genetics Corp - ‍announced that it has entered into a clinical collaboration agreement with AstraZeneca​

* NewLink Genetics Corp - NewLink Genetics’ share of aggregate expense of trial is not expected to have a material effect on its financial position​

* NewLink Genetics Corp - ‍patients will also be enrolled into a smaller cohort evaluating combination of durvalumab with gemcitabine/abraxane​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below